SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 18.39 |
| Enterprise Value ($M) | 11.44 |
| Book Value ($M) | 24.88 |
| Book Value / Share | 3.73 |
| Price / Book | 0.74 |
| NCAV ($M) | 24.87 |
| NCAV / Share | 3.73 |
| Price / NCAV | 0.74 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.87 |
| Return on Assets (ROA) | -0.46 |
| Return on Equity (ROE) | -0.57 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 9.66 |
| Current Ratio | 9.66 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 27.75 |
| Assets | 27.75 |
| Liabilities | 2.87 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 65.30 |
| Operating Income | 25.44 |
| Net Income | 17.78 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -50.47 |
| Cash from Investing | 49.14 |
| Cash from Financing | -11.87 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Tang Capital Partners Lp | 4.90 | -9.69 | |
| 13G/A | Vanguard Group Inc | 5.85 | ||
| 13D/A | Anson Funds Management LP | 16.40 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 742 | 9,643 | 7.69 | |
| 1,484 | 17,508 | 8.48 | |
| 749 | 11,972 | 6.26 | |
| 3,904 | 18,873 | 20.69 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| MBIO – Mustang Bio, Inc. | MBRX – Moleculin Biotech, Inc. |
| ME – 23andMe Holding Co. | MIRA – MIRA Pharmaceuticals, Inc. |
| MLTX – MoonLake Immunotherapeutics |